Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/31267
DC FieldValueLanguage
dc.contributor.authorLalam, Radheshen_US
dc.contributor.authorBloem, Johan Len_US
dc.contributor.authorNoebauer-Huhmann, Iris Men_US
dc.contributor.authorWörtler, Klausen_US
dc.contributor.authorTagliafico, Albertoen_US
dc.contributor.authorVanhoenacker, Filipen_US
dc.contributor.authorVasilevska Nikodinovska, Violetaen_US
dc.contributor.authorSanal, Hatice Tubaen_US
dc.contributor.authorWoude, Henk-Jan van deren_US
dc.contributor.authorPapakonstantinou, Olympiaen_US
dc.contributor.authorÅström, Gunnaren_US
dc.contributor.authorDavies, Marken_US
dc.contributor.authorIsaac, Amandaen_US
dc.contributor.authorWeber, Marc-Andréen_US
dc.date.accessioned2024-09-05T08:56:56Z-
dc.date.available2024-09-05T08:56:56Z-
dc.date.issued2017-11-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/31267-
dc.description.abstractBenign bone tumors are rare but are more common than primary malignant bone tumors. The early accurate diagnosis and reliable differentiation of these rare benign tumors and tumor mimickers from the even rarer malignant tumors with subsequent appropriate treatment or watchful waiting is crucial for the clinical outcome. Bone tumors are often a source of diagnostic and therapeutic uncertainty. Thus this European Society of Musculoskeletal Radiology consensus document is intended to help radiologists in their decision making and support discussion among clinicians who deal with patients with suspected or proven bone tumors. Evaluating these tumors starts with a patient history and physical examination. Radiography is the principal imaging modality and often can reliably diagnose a benign bone tumor by providing information about localization, matrix, aggressiveness, size, and (potential) multiplicity. In a significant number of cases, additional imaging is not necessary. Potentially malignant entities recognized by radiography should be referred for magnetic resonance imaging, which also serves as a preoperative local staging modality, with specific technical requirements. Indeterminate tumors, or tumors in which therapy depends on histology results, should be biopsied. For biopsy, we strongly recommend referral to a specialist regional sarcoma treatment center (RSTC), where a multidisciplinary tumor team, including a specialist pathologist, radiologist, and sarcoma surgeon, are involved. Additional staging modalities are entity specific and should be performed according to the recommendations of the RSTC.en_US
dc.language.isoenen_US
dc.publisherGeorg Thieme Verlag KGen_US
dc.relation.ispartofSeminars in Musculoskeletal Radiologyen_US
dc.subjectbone tumoren_US
dc.subjectbone tumor mimickersen_US
dc.subjectconsensus statementen_US
dc.subjectdiagnostic algorithmen_US
dc.subjectimaging methodsen_US
dc.subjectESSRen_US
dc.titleESSR Consensus Document for Detection, Characterization, and Referral Pathway for Tumors and Tumorlike Lesions of Boneen_US
dc.typeArticleen_US
dc.identifier.doi10.1055/s-0037-1606130-
dc.identifier.urlhttp://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0037-1606130.pdf-
dc.identifier.volume21-
dc.identifier.issue5-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

42
checked on May 4, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.